This research program is directed towards an understanding of the neurochemical and behavioral correlates of the decline in cognition and memory with age and in Alzheimer's Disease (AD). The ultimate goal is the development of preventative or ameliorative treatments for this decline. The investigations focus on age-associated changes in the rat nucleus basalis magnocellularis (NBM), an area analogous to the nucleus basalis of Meynert in humans. During normal aging and in AD the brain develops a complicated pattern of degenerative changes including, but not limited to, the loss of specific neural systems that underlie the normal mechanisms associated with memory. The loss of cells in the nucleus basalis of Meynert may be responsible for this memory impairment. The nature of the selection process that leads to the degeneration of cells within the NBM is unknown, although endogenous excitatory amino acids have been implicated. In addition, the identity of the cell, or cells, in this nucleus whose degeneration leads to the development of the memory impairment, is also unknown. The assumption has been that the loss of cholinergic cells is sufficient to produce the memory deficit. Previous research from this laboratory has raised significant doubt about the validity of this assumption. However, the NBM region contains many noncholinergic neurotransmitter systems and their role in age- and dementia-associated memory deficits has not been investigated. This project addresses the following hypothesis related to the mechanisms of NBM neuronal cell death associated with aging: if neurons in the NBM demonstrate an age-related differential vulnerability to excitatory amino acid neurotoxins, such as 2-amino-3-hydroxy-5-methylisoxazole-4- proprionicacid (AMPA) or N-methyl-d-aspartate (NMDA), then these neurotoxins should produce differential behavioral and biochemical consequences in young, adult and old rats. This hypothesis will be tested by producing lesions within the basal forebrain of rats; studying the behavioral changes that develop; examining the histological and biochemical changes in the brain following the lesions; and correlating the changes in specific neuronal markers with performance in the behavioral tasks. These experiments have significant implications for our understanding of the differential vulnerability of specific NBM neurons with aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG010546-01A3
Application #
2051781
Study Section
Neurology A Study Section (NEUA)
Project Start
1994-04-08
Project End
1997-03-31
Budget Start
1994-04-08
Budget End
1995-03-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Arizona
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Rosi, S; Ramirez-Amaya, V; Vazdarjanova, A et al. (2009) Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine. Brain 132:2464-77
Marchalant, Yannick; Cerbai, Francesca; Brothers, Holly M et al. (2008) Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Neurobiol Aging 29:1894-901
Marchalant, Yannick; Brothers, Holly M; Wenk, Gary L (2008) Inflammation and aging: can endocannabinoids help? Biomed Pharmacother 62:212-7
Burke, Sara N; Maurer, Andrew P; Yang, Zhiyong et al. (2008) Glutamate receptor-mediated restoration of experience-dependent place field expansion plasticity in aged rats. Behav Neurosci 122:535-48
Marchalant, Y; Rosi, S; Wenk, G L (2007) Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neuroscience 144:1516-22
Marriott, L K; McGann-Gramling, K R; Hauss-Wegrzyniak, B et al. (2007) Brain infusion of lipopolysaccharide increases uterine growth as a function of estrogen replacement regimen: suppression of uterine estrogen receptor-alpha by constant, but not pulsed, estrogen replacement. Endocrinology 148:232-40
Rosi, S; Vazdarjanova, A; Ramirez-Amaya, V et al. (2006) Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience 142:1303-15
Rosi, S; Pert, C B; Ruff, M R et al. (2005) Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease. Neuroscience 134:671-6
Mohmmad Abdul, Hafiz; Wenk, Gary L; Gramling, McGann et al. (2004) APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease. Neurosci Lett 368:148-50
Wenk, Gary L; McGann-Gramling, Kristin; Hauss-Wegrzyniak, Beatrice et al. (2004) Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid. J Neurochem 89:484-93

Showing the most recent 10 out of 47 publications